what is the difference between semaglutide and retatrutide GLP-1 Medications for Weight Loss: vs Tirzepatide vs Retat – Revolution Health & Wellness Retatrutide vs. Semaglutide: How Do

Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, et al

BMC Public Health 26, 457 (2026)

Side effects whats common, whats rare, whats exaggerated Ordered by real-world frequency

Choose filling, lower-calorie snacks like apple slices, popcorn, carrot sticks, or hard-boiled eggs

Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025

The weight loss figures from clinical trials for these three medications tell a compelling story, one where each generation of treatment meaningfully outperforms the last